Literature DB >> 20300214

SLAM-family receptors: immune regulators with or without SAP-family adaptors.

André Veillette1.   

Abstract

The signaling lymphocytic activation molecule (SLAM) family of receptors and the SLAM-associated protein (SAP) family of intracellular adaptors are expressed in immune cells. By way of their cytoplasmic domain, SLAM-related receptors physically associate with SAP-related adaptors. Evidence is accumulating that the SLAM and SAP families play crucial roles in multiple immune cell types. Moreover, the prototype of the SAP family, that is SAP, is mutated in a human immunodeficiency, X-linked lymphoproliferative (XLP) disease. In the presence of SAP-family adaptors, the SLAM family usually mediates stimulatory signals that promote immune cell activation or differentiation. In the absence of SAP-family adaptors, though, the SLAM family undergoes a "switch-of-function," thereby mediating inhibitory signals that suppress immune cell functions. The molecular basis and significance of this mechanism are discussed herein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300214      PMCID: PMC2829957          DOI: 10.1101/cshperspect.a002469

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  74 in total

Review 1.  X-linked lymphoproliferative disease: a progressive immunodeficiency.

Authors:  M Morra; D Howie; M S Grande; J Sayos; N Wang; C Wu; P Engel; C Terhorst
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.

Authors:  S Latour; G Gish; C D Helgason; R K Humphries; T Pawson; A Veillette
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

3.  Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family.

Authors:  A Bouchon; M Cella; H L Grierson; J I Cohen; M Colonna
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta.

Authors:  M Kruse; E Meinl; G Henning; C Kuhnt; S Berchtold; T Berger; G Schuler; A Steinkasserer
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

5.  Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines.

Authors:  J R Bleharski; K R Niazi; P A Sieling; G Cheng; R L Modlin
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

6.  Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity.

Authors:  G Henning; M S Kraft; T Derfuss; R Pirzer; G de Saint-Basile; G Aversa; B Fleckenstein; E Meinl
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

7.  SAP couples Fyn to SLAM immune receptors.

Authors:  Betty Chan; Arpad Lanyi; Hyun Kyu Song; Jan Griesbach; Maria Simarro-Grande; Florence Poy; Duncan Howie; Janos Sumegi; Cox Terhorst; Michael J Eck
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

8.  Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation.

Authors:  Sylvain Latour; Romain Roncagalli; Riyan Chen; Marcin Bakinowski; Xiaochu Shi; Pamela L Schwartzberg; Dominique Davidson; André Veillette
Journal:  Nat Cell Biol       Date:  2003-02       Impact factor: 28.824

9.  Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation.

Authors:  Simona Sivori; Michela Falco; Emanuela Marcenaro; Silvia Parolini; Roberto Biassoni; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

10.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.

Authors:  C Bottino; M Falco; S Parolini; E Marcenaro; R Augugliaro; S Sivori; E Landi; R Biassoni; L D Notarangelo; L Moretta; A Moretta
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  54 in total

1.  A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.

Authors:  Ning Wu; Ming-Chao Zhong; Romain Roncagalli; Luis-Alberto Pérez-Quintero; Huaijian Guo; Zhanguang Zhang; Christelle Lenoir; Zhongjun Dong; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2016-02-15       Impact factor: 25.606

2.  CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells.

Authors:  Damiana Álvarez-Errico; Irene Oliver-Vila; Erola Ainsua-Enrich; Alasdair M Gilfillan; César Picado; Joan Sayós; Margarita Martín
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

3.  Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy.

Authors:  Yasser A Aldhamen; Sergey S Seregin; Charles F Aylsworth; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2013-12-27       Impact factor: 4.823

Review 4.  Control of early stages in invariant natural killer T-cell development.

Authors:  Taishan Hu; Idoia Gimferrer; José Alberola-Ila
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

Review 5.  Signaling in lymphocyte activation.

Authors:  Doreen Cantrell
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-06-01       Impact factor: 10.005

6.  Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

Authors:  Lishomwa C Ndhlovu; Sandra Lopez-Vergès; Jason D Barbour; R Brad Jones; Aashish R Jha; Brian R Long; Eric C Schoeffler; Tsuyoshi Fujita; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

Review 7.  Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment.

Authors:  Hila Magen; Eli Muchtar
Journal:  Ther Adv Hematol       Date:  2016-06-10

8.  Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells.

Authors:  Huaijian Guo; Mario-Ernesto Cruz-Munoz; Ning Wu; Michael Robbins; André Veillette
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

Review 9.  Natural killer cell cytotoxicity and its regulation by inhibitory receptors.

Authors:  Santosh Kumar
Journal:  Immunology       Date:  2018-04-11       Impact factor: 7.397

10.  The chicken SLAM family.

Authors:  Christian Straub; Birgit C Viertlboeck; Thomas W Göbel
Journal:  Immunogenetics       Date:  2012-10-13       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.